Spyre Therapeutics (SYRE) Receivables - Other (2021 - 2023)
Spyre Therapeutics (SYRE) posted Receivables - Other of $163000.0 for Q3 2023, down 90.1% on a QoQ basis from $1.6 million in Q2 2023, and down 75.64% year-over-year from $669000.0 in Q3 2022.
Spyre Therapeutics (SYRE) Receivables - Other (2021 - 2023) Analysis & Trends
Spyre Therapeutics' Receivables - Other history runs 3 years deep, the most recent figure standing at $163000.0 for Q3 2023.
- Quarterly Receivables - Other fell 75.64% year-over-year to $163000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $163000.0 (down 75.64% YoY) and the FY2022 annual result came in at $375000.0, down 53.99% from the prior year.
- Receivables - Other was $163000.0 for Q3 2023 at Spyre Therapeutics, down from $1.6 million in the prior quarter.
- Across five years, Receivables - Other topped out at $1.6 million in Q2 2023 and bottomed at $163000.0 in Q3 2023.
- A 3-year average of $686125.0 and a median of $574000.0 in 2022 frame the typical range for Receivables - Other.
- Peak annual rise in Receivables - Other reached 243.63% in 2023, while the deepest fall reached 75.64% in 2023.
- Spyre Therapeutics' Receivables - Other stood at $815000.0 in 2021, then sank by 53.99% to $375000.0 in 2022, then sank by 56.53% to $163000.0 in 2023.
- Business Quant data shows SYRE's Receivables - Other at $163000.0 in Q3 2023, $1.6 million in Q2 2023, and $330000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 163,000.00 |
| Sep 30, 2023 | 163,000.00 |
| Jun 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 330,000.00 |
| Mar 31, 2023 | 330,000.00 |
| Dec 31, 2022 | 375,000.00 |
| Dec 31, 2022 | 375,000.00 |
| Sep 30, 2022 | 669,000.00 |
| Sep 30, 2022 | 669,000.00 |
| Jun 30, 2022 | 479,000.00 |
| Jun 30, 2022 | 479,000.00 |
| Mar 31, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 815,000.00 |
| Dec 31, 2021 | 815,000.00 |